Gudmundsdottir T,Winther JF,de Fine LS,et al.Cardiovascular disease in adult life after childhood cancer in Scandinavia:A population-based cohort study of32 308one-year survivors[J].Int J Cancer,2015,137(5):1 176-1 186.
[2]
Biondi B.Mechanisms in endocrinology:Heart failure and thyroid dysfunction[J].Eur J Endocrinol,2012,167(5):609-618.
[3]
Eustatia-Rutten CF,Corssmit EP,Biermasz NR,et al.Survival and death causes in differentiated thyroid carcinoma[J].J Clin Endocrinol Metab,2006,91(1):313-319.
[4]
Grais IM,Sowers JR.Thyroid and the heart[J].Am JMed,2014,127(8):691-698.
[5]
Danese MD,Ladenson PW,Meinert CL,et al.Clinical review 115:Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure:A quantitative review of the literature[J].J Clin Endocrinol Metab,2000,85(9):2 993-3 001.
[6]
Iervasi G,Molinaro S,Landi P,et al.Association between increased mortality and mild thyroid dysfunction in cardiac patients[J].Arch Intern Med,2007,167(14):1 526-1 532.
[7]
Rotondi M,Magri F,Chiovato L.Risk of coronary heart disease and mortality for adults with subclinical hypothyroidism[J].JAMA,2010,304(22):2 481-2 482.
[8]
Siegel RL,Miller KD,Jemal A.Cancer statistics,2017[J].CA Cancer J Clin,2017,67(1):7-30.
[9]
Aschebrook-Kilfoy B,Kaplan EL,Chiu BC,et al.The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States[J].Ann Surg Oncol,2013,20(8):2 746-2 753.
Pellegriti G,Frasca F,Regalbuto C,et al.Worldwide increasing incidence of thyroid cancer:Update on epidemiology and risk factors[J].J Cancer Epidemiol,2013,2013:965 212.
[12]
Lubitz CC,Sosa JA.The changing landscape of papillary thyroid cancer:Epidemiology,management,and the implications for patients[J].Cancer,2016,122(24):3 754-3 759.
[13]
Yang L,Shen W,Sakamoto N.Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer[J].J Clin Oncol,2013,31(4):468-474.
[14]
Klein HE,Klein HM,de Bock GH,et al.Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma:An observational study[J].J Clin Oncol,2013,31(32):4 046-4 053.
[15]
Klein I,Ojamaa K.Thyroid hormone and the cardiovascular system[J].N Engl J Med,2001,344(7):501-509.
[16]
Boekholdt SM,Titan SM,Wiersinga WM,et al.Initial thyroid status and cardiovascular risk factors:The EPIC-Norfolk prospective population study[J].Clin Endocrinol(Oxf),2010,72(3):404-410.
[17]
Tatar E,Kircelli F,Ok E.The contribution of thyroid dysfunction on cardiovascular disease in patients with chronic kidney disease[J].Atherosclerosis,2013,227(1):26-31.
[18]
Moura NA,Parisi MC,Tambascia MA,et al.Relationship of thyroid hormone levels and cardiovascular events in patients with type 2diabetes[J].Endocrine,2014,45(1):84-91.
[19]
Selmer C,Olesen JB,Hansen ML,et al.Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events:A large population study[J].J Clin Endocrinol Metab,2014,99(7):2 372-2 382.
[20]
Cooper DS,Biondi B.Subclinical thyroid disease[J].Lancet,2012,379(9 821):1 142-1 154.
[21]
Fine JP,Gray RJ.A Proportional hazards model for the subdistribution of a competing risk[J].J Amer Statist Assoc,1999,94(446):496-509.
[22]
Iervasi G,Nicolini G.Thyroid hormone and cardiovascular system:From basic concepts to clinical application[J].Intern Emerg Med,2013,8(Suppl 1):S71-S74.
[23]
Vargas-Uricoechea H,Bonelo-Perdomo A,SierraTorres CH.Effects of thyroid hormones on the heart[J].Clin Investig Arterioscler,2014,26(6):296-309.
Rugbjerg K,Mellemkjaer L,Boice JD,et al.Cardiovascular disease in survivors of adolescent and young adult cancer:a Danish cohort study,1943-2009[J].JNatl Cancer Inst,2014,106(6):dju110.
Cooper DS,Biondi B.Subclinical thyroid disease[J].Lancet,2012,379(9 821):1 142-1 154.
[28]
McQuade C,Skugor M,Brennan DM,et al.Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors:a PreCIS database study[J].Thyroid,2011,21(8):837-843.
[29]
Noone AM,Lund JL,Mariotto A,et al.Comparison of SEER treatment data with Medicare claims[J].Med Care,2016,54(9):e55-e64.
[30]
John RT,Mark JR,Paul CL.Age-period-cohort modeling[J].Stata Journal,2010,10:606-627.
[31]
Gussekloo J,van Exel E,de Craen AJ,et al.Thyroid status,disability and cognitive function,and survival in old age[J].JAMA,2004,292(21):2 591-2 599.
[32]
Selmer C,Olesen JB,Hansen ML,et al.Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events:A large population study[J].J Clin Endocrinol Metab,2014,99(7):2 372-2 382.
